MedPath

Terconazole

TERCONAZOLE VAGINAL CREAM 0.4%

Approved
Approval ID

5527cd23-567b-4019-8e5c-f71ee7ed2689

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 1, 2010

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Terconazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-844
Application NumberANDA076043
Product Classification
M
Marketing Category
C73584
G
Generic Name
Terconazole
Product Specifications
Route of AdministrationVAGINAL
Effective DateAugust 25, 2008
FDA Product Classification

INGREDIENTS (9)

TerconazoleActive
Quantity: 4 mg in 1 g
Code: 0KJ2VE664U
Classification: ACTIB
isopropyl myristateInactive
Code: 0RE8K4LNJS
Classification: IACT
butylated hydroxyanisoleInactive
Code: REK4960K2U
Classification: IACT
POLYSORBATE 60Inactive
Code: CAL22UVI4M
Classification: IACT
cetyl alcoholInactive
Code: 936JST6JCN
Classification: IACT
propylene glycolInactive
Code: 6DC9Q167V3
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT
stearyl alcoholInactive
Code: 2KR89I4H1Y
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Terconazole - FDA Drug Approval Details